Author:

People living with type 2 diabetes have a higher risk of coronary heart disease (CHD). In a CHDS seminar, Bart Ferket discussed using risk stratification to prevent CHD among diabetics.

Jacob Jameson, first-year student in the Harvard PhD Program in Health Policy, has received the 2022 Howard Raiffa Fund award. The Howard Raiffa Fund was established in 1996

The social value of decreasing health risks to people of different age, health status, and income depends on the evaluation framework employed in an analysis. These values can be evaluated using cost-effectiveness

Fangli Geng, Ph.D. candidate at CHDS, collaborated with researchers from the Chinese Academy of Medical Sciences & Peking Union Medical College to develop

COVID-19 vaccination is substantially more cost-effective than lockdowns, according to research conducted by CHDS faculty affiliate Joseph Pliskin and Ronen Arbel. Early in the COVID-19

The EPIC team at CHDS, led by CHDS faculty Stephen Resch, performed a systematic review of literature to describe research on the costs and cost-effectiveness of integrating

Jinyi Zhu, 6th year doctoral student in Decision Science/Health Policy, successfully defended her thesis, “Decision Modeling to Inform Resource Prioritization: Methods and

FAMNET research assistant Cassidy Bargell faced quality of life decision making in real-time last fall when confronted with a serious illness. As described recently in a Harvard Gazette feature article, Cass experienced

Jeremy Goldhaber-Fiebert discussed his work on informing COVID-19 policy decisions at a recent CHDS seminar. Goldhaber-Fiebert is a Professor of Health Policy at Stanford and

Maurice Smith discussed the human brain’s control of motor behavior and learning in a recent CHDS seminar. Smith is Professor of Bioengineering at the Harvard Paulson School of Engineering and